Institution Directory

Clinical trials at Brigham and Women's Hospital

Sites in Boston, MA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 7:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

742

Shown on this page

Current sort

Stored official records

Conditions: Clostridioides Difficile Infection, Inflammatory Bowel Disease (IBD)
Interventions: Xylitol; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Lymphocytic Leukemia, Leukemia, Lymphoma, Small Lymphocytic Lymphoma
Interventions: Acalabrutinib, Ibrutinib, Mosunetuzumab, Pirtobrutinib, Zanubrutinib; Drug
Lead sponsor: Inhye Ahn; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Intraoral Photobiomodulation Therapy, Mucosal Ulcer, Myeloablative Allogeneic Hematopoietic Cell Transplantation, Oral Mucositis
Interventions: THOR LX2.3 with LED Lollipop; Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE, Preterm Less Than 32wks With IVH, WMI/PVL
Interventions: Prospective Clinical and Neurodevelopmental Data Collection; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 31 Weeks to 42 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glucose Tolerance, Sex Differences, Sleep Deprivation
Interventions: Sleep restriction; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 40 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight and Obesity
Interventions: 24-hour ambulatory blood pressure, Liberal salt diet; Diagnostic Test · Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypoxic Ischemic Brain Injury, Neonatal Encephalopathy
Interventions: Near-Infrared Spectroscopy (NIRS); Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 2 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2028
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Pulmonary Arterial Hypertension
Interventions: Oral Treprostinil, Parenteral Treprostinil; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 28
States / cities: Phoenix, Arizona • Fresno, California • Los Angeles, California + 23 more

Conditions: Hypertension, Insulin Resistance
Interventions: Angiotensin II, Norepinephrine, Para-aminohippuric Acid; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Appetitive Behavior, Obesity
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Belmont, Massachusetts • Boston, Massachusetts

Conditions: Dietary Habits
Interventions: dietary intervention; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bariatric Surgery, Obesity, Sleeve Gastrectomy
Interventions: Dietary habits plan; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 22 Years to 62 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

About this Brigham and Women's Hospital institution page

What this page lists: ClinicalTrials.gov records that list Brigham and Women's Hospital in Boston, MA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Brigham and Women's Hospital

Filter and sort this campus

Stored official records

Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease

Mosunetuzumab for CLL MRD Clearance

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Caveolin-1 and Vascular Dysfunction

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Dietary Intervention to Mitigate Adverse Consequences of Night Work

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C

About this Brigham and Women's Hospital institution page